Quantitative Multi-Parametric MRI of the Prostate Reveals Racial Differences
<b>Purpose:</b> This study investigates whether quantitative MRI and histology of the prostate reveal differences between races, specifically African Americans (AAs) and Caucasian Americans (CAs), that can affect diagnosis. <b>Materials and Methods:</b> Patients (98 CAs, 47 AAs) with known or suspected prostate cancer (PCa) underwent 3T MRI (T2W, DWI, and DCE-MRI) prior to biopsy or prostatectomy. Quantitative mpMRI metrics: ADC, T2, and DCE empirical mathematical model parameters were calculated. <b>Results:</b> AAs had a greater percentage of higher Gleason-grade lesions compared to CAs. There were no significant differences in the quantitative ADC and T2 values between AAs and CAs. The cancer signal enhancement rate (α) on DCE-MRI was significantly higher for AAs compared to CAs (AAs: 13.3 ± 9.3 vs. CAs: 6.1 ± 4.7 s<sup>-1</sup>, <i>p</i> < 0.001). The DCE signal washout rate (β) was significantly lower in benign tissue of AAs (AAs: 0.01 ± 0.09 s<sup>-1</sup> vs. CAs: 0.07 ± 0.07 s<sup>-1</sup>, <i>p</i> < 0.001) and significantly elevated in cancer tissue in AAs (AAs: 0.12 ± 0.07 s<sup>-1</sup> vs. CAs: 0.07 ± 0.08 s<sup>-1</sup>, <i>p</i> = 0.02). DCE significantly improves the differentiation of PCa from benign in AAs (α: 52%, β: 62% more effective in AAs compared to CAs). Histologic analysis showed cancers have a greater proportion (<i>p</i> = 0.04) of epithelium (50.9 ± 12.3 vs. 44.7 ± 12.8%) and lower lumen (10.5 ± 6.9 vs. 16.2 ± 6.8%) in CAs compared to AAs. <b>Conclusions:</b> This study shows that AAs have different quantitative DCE-MRI values for benign prostate and prostate cancer and different histologic makeup in PCa compared to CAs. Quantitative DCE-MRI can significantly improve the performance of MRI for PCa diagnosis in African Americans but is much less effective for Caucasian Americans.
Authors
- Aytekin Oto (ORCID: https://orcid.org/0000-0003-4325-2489)
- Ambereen Yousuf (ORCID: https://orcid.org/0000-0002-0475-9087)
- Aritrick Chatterjee (ORCID: https://orcid.org/0000-0003-4022-7106)
- Tatjana Antic (ORCID: https://orcid.org/0000-0002-0455-9413)
- Milica Medved (ORCID: https://orcid.org/0000-0003-2945-5511)
- George Awuku Asare (ORCID: https://orcid.org/0000-0002-8002-5579)
- Gregory S. Karczmar (ORCID: https://orcid.org/0000-0002-2455-5858)
- Xiaobing Fan (ORCID: https://orcid.org/0000-0001-9004-029X)
- Scott Eggener (ORCID: https://orcid.org/0000-0002-5748-3790)
- Jessica Slear
Institutions
- University of Chicago (US)
Publication Details
- Journal
- Cancers
- Published
- 2024-10-16
- DOI
- https://doi.org/10.3390/cancers16203499
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- University of Chicago
- Sanford J. Grossman Charitable Trust